• Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say
  • First Patient Enrolled in Phase 2 Trial of EPX-100, Potential Add-on Therapy for Dravet
  • There’s No Guarantee in the World of Dravet Syndrome
  • Eisai Begins Phase 3 Trial Testing Lorcaserin at Reducing Dravet Seizure Frequency
  • When Special Needs Parents Band Together
  • Same But Different Asks Public to Vote on ‘Glimmer of Hope’ Calendar Photos
  • Meeting Austen’s Baby Doll, Sarah
  • Dravet Syndrome Foundation Readies for Online ‘Day of Dravet’
  • Fycompa May Open to Younger Children With Select Seizures in Europe
  • How Milo Became Girl’s Best Friend
  • Fintepla Reduces Seizure Frequency in Dravet Syndrome Youngsters, Pivotal Phase 3 Trial Reports
  • Fintepla Unlikely to Cause Heart Valve Problems, PAH in Young Patients, Extension Study Finds